ISPC

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

Wall Street analysts forecast ISPC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISPC is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

iSpecimen Inc revenue for the last quarter amounts to 106.59K USD, decreased -96.00 % YoY.

iSpecimen Inc. EPS for the last quarter amounts to -0.48 USD, decreased -77.14 % YoY.

iSpecimen Inc (ISPC) has 24 emplpoyees as of January 07 2026.

Today ISPC has the market capitalization of 3.12M USD.